Tonghua Dongbao Pharmaceutical Co Ltd (600867.SS)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|62||2007||Chairman of the Board|
|49||Chief Accounting Officer, Secretary of the Board, Director|
|46||2007||General Manager, Director|
|40||2007||Deputy General Manager, Director|
|39||2012||Deputy General Manager, Chief Engineer|
- China stocks deepen rout on economic worries, falling yuan
- BRIEF-Shanghai Exchange Filing Shows Block Trade Of Tonghua Dongbao Pharma Involving 459.42 Mln Yuan
- China stocks extend losses, consumer and real estate firms weigh
- BRIEF-Tonghua Dongbao Pharmaceutical Signs Agreements With SA Adocia On Insulin-Related Products
- BRIEF-Adocia And Tonghua Dongbao Announce A Strategic Alliance For Biochaperone Combo And Biochaperone Lispro In China